LENAMIDE 25 mg Price

Overview

Welcome to Dwaey, specifically on LENAMIDE 25 mg Capsules (Hard Gelatin) page.
This medicine contains an important and useful components, as it consists of Lenalidomide.
LENAMIDE 25 mg is available in the market in concentration 25 mg/Capsule and in the form of Capsules (Hard Gelatin).

EVA PHARMA FOR PHARMACEUTICALS & MEDICAL APPLIANCES is the producer of LENAMIDE 25 mg and it is imported from EGYPT, The most popular alternatives of LENAMIDE 25 mg are listed downward .

Mode Of Action

Leflunomide is an immunomodulating agent and DMARD. It inhibits pyrimidine synthesis by inhibiting dihydroorotate dehydrogenase enzyme activity resulting in antiproliferative and anti-inflammatory effects.

Indication

• Rheumatoid arthritis
• Psoriatic arthritis

Precaution

Renal and hepatic impairment; Women with childbearing potential. Caution should be taken for those female with child bearing potential who are not using reliable contraception and for the subject of renal insufficiency. Leflunomide should be stopped before becoming pregnant. Liver function should be monitored before starting treatment. Monitor blood counts and BP regularly. Avoid alcohol. Lactation: not known if excreted in breast milk

Side Effects

• >10% Diarrhea (17%)
• Respiratory infections (15%) 1-10% (selected) Alopecia (10%)
• Hypertension (10%)
• Rash (10%)
• Nausea (9%)
• Bronchitis (7%)
• Headache (7%)
• Abdominal pain (5%)
• Abnormal LFT's (5%)
• Accidental injury (5%)
• Back pain (5%)
• Dyspepsia (5%)
• UTI (5%)
• Dizziness (4%)
• Infection (4%)
• Joint disorder (4%)
• Pruritus (4%)
• Weight loss (4%)
• Anorexia (3%)
• Cough (3%)
• Gastroenteritis (3%)
• Pharyngitis (3%)
• Stomatitis (3%)
• Tenosynovitis (3%)
• Vomiting (3%)
• Weakness (3%)
• Allergic reaction (2%)
• Chest pain (2%)
• Dry skin (2%)
• Eczema (2%)
• Pain (2%)
• Paresthesia (2%)
• Pneumonia (2%)
• Rhinitis (2%)
• Sinusitis (2%)
• Synovitis (2%) Potentially Fatal: Hepatotoxicity.

Contra indication

Significant hepatic impairment, compromised immune function including bone marrow dysplasia or severe uncontrolled infection; concurrent vaccination with live vaccines. Pregnancy, lactation.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.